Neuroscience
Glial Cell Line-Derived Neurotrophic Factor
86%
Parkinson's Disease
79%
Tetrahydropyridine
76%
Magnetic Resonance Imaging
76%
L-DOPA
58%
Dyskinesia
56%
Basal Ganglia
54%
In Vivo
48%
In Vitro
48%
Striatum
47%
Putamen
40%
Apomorphine
38%
Dopaminergic
36%
Parenchyma
28%
MPTP
27%
Receptor Antagonist
27%
Adenosine
27%
Denervation
24%
4 Aminobutyric Acid B Receptor
21%
Dopamine Transporter
21%
Blood-Oxygen-Level Dependent
21%
Huntingtin
21%
Small Interfering RNA
21%
Motor Learning
21%
Messenger RNA
21%
Receptor
21%
Glutamic Acid
19%
Substantia Nigra Pars Compacta
16%
Neurturin
14%
Iodine-125
13%
Benserazide
13%
Treatment of Parkinson's Disease
12%
Neuroprotective Agent
12%
Oxidopamine
12%
Tyrosine Hydroxylase
11%
Globus pallidus
11%
Parkinsonism
11%
Behavior (Neuroscience)
10%
Substantia nigra
10%
Neurotrophic Factor
10%
Brain Cancer
10%
Agarose
10%
Midbrain
10%
Dopamine Receptor D2
9%
Caudate Nucleus
8%
Neurotoxin
8%
Enkephalin
7%
Amino Acid
7%
Heparin
7%
Placebo
7%
Extracellular Matrix
7%
Neurodegenerative Disorder
6%
Gamma-Aminobutyric Acid
6%
Dopamine Receptor
5%
Motor Cortex
5%
Magnetic Resonance Imaging
5%
Behavioral Test
5%
Gyri
5%
Neuronal Activity
5%
Primary Motor Cortex
5%
Raclopride
5%
GABAA Receptor
5%
Presynaptic Inhibition
5%
Proenkephalin
5%
NMDA Receptor
5%
Receptor Occupancy
5%
N-Methyl-D-Aspartic Acid
5%
Gene Expression
5%
Ionotropic Receptor
5%
Cabergoline
5%
Gramicidin
5%
Cell Death
5%
Parkinson's Disease Clinical Trial
5%
Cytochrome C
5%
Cytotoxicity
5%
Staurosporine
5%
Caspase 3
5%
Mitochondrion
5%
Electroencephalogram
5%
Pharmacology, Toxicology and Pharmaceutical Science
Dyskinesia
100%
1,2,3,6 Tetrahydro 1 Methyl 4 Phenylpyridine
95%
Haplorhini
80%
Glial Cell Line Derived Neurotrophic Factor
43%
Biodistribution
43%
Mammalia
43%
Antiparkinson Agent
30%
Rhesus Monkey
28%
Pathophysiology
24%
4 Aminobutyric Acid B Receptor
21%
Mitochondrial Permeability Transition Pore
21%
Levodopa-Induced Dyskinesia
21%
Dopamine Transporter
21%
Receptor Antagonist
21%
Adenosine
21%
Idazoxan
21%
Parkinson's Disease
21%
DOPA
17%
Receptor
16%
Glutamic Acid
16%
Benserazide
15%
Levodopa
15%
Messenger RNA
15%
Neurturin
14%
Iodine-125
13%
Dopamine Receptor Stimulating Agent
11%
Dopamine Receptor D2
9%
Enkephalin
8%
4 Aminobutyric Acid
8%
Drug Distribution
7%
Drug Discovery
7%
Drug Development
7%
Clinical Trial
7%
Chemical Stability
7%
Escherichia coli
7%
Placebo
7%
Amino Acid
7%
Heparin
7%
Drug Repositioning
7%
Oxidopamine
7%
Neuroprotective Agent
7%
Volume of Distribution
7%
Diseases
7%
Macaca fascicularis
6%
Cgp 64213
5%
Ionotropic Receptor
5%
Cabergoline
5%
Adenosine A2a Receptor
5%
N Methyl Dextro Aspartic Acid Receptor
5%
N Methyl Dextro Aspartic Acid
5%
Proenkephalin
5%